2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry

被引：0
|
作者：
Pol, D. [1 ]
Chowdhury, E. [2 ]
Delacroix, S. [3 ]
Worthley, S. [3 ]
Eccleston, D. [1 ]
机构：
[1] Royal Melbourne Hosp, Melbourne, Vic, Australia
[2] Monash Univ, Clin Epidemiol, Melbourne, Vic, Australia
[3] GenesisCare Cardiol, Sydney, NSW, Australia
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1731 / 1731
页数：1
相关论文
共 50 条
  • [1] TICAGRELOR OR PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC CORONARY SYNDROMES: RESULTS FROM A REAL-WORLD REGISTRY
    Koshy, Anoop Ninan
    Giustino, Gennaro
    Sartori, Samantha
    Hooda, Amit
    Feng, Yihan
    Snyder, Clayton
    Smith, Kenneth
    Kumar, Kartik
    Chen, Shiwei
    Krishnamoorthy, Parasuram Melarcode
    Dhulipala, Vishal
    Sweeny, Joseph M.
    Khera, Sahil
    Serrao, Gregory
    Sharma, Raman
    Dangas, George D.
    Kini, Annapoorna Subhash
    Mehran, Roxana
    Sharma, Samin K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1298 - 1298
  • [2] Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
    Krishnamurthy, Arvindra
    Keeble, Claire
    Anderson, Michelle
    Somers, Kathryn
    Burton-Wood, Natalie
    Harland, Charlotte
    Baxter, Paul
    McLenachan, Jim
    Blaxill, Jonathan
    Blackman, Daniel J.
    Malkin, Christopher
    Wheatcroft, Stephen
    Greenwood, John
    OPEN HEART, 2019, 6 (01):
  • [3] CLINICAL OUTCOMES FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION: A COMPARISON OF CLOPIDOGREL, PRASUGREL AND TICAGRELOR
    Krishnamurthy, Arvindra
    Keeble, Claire M.
    Burton-Wood, Natalie
    Somers, Kathryn
    Anderson, Michelle
    Harland, Charlotte
    McLenachan, James M.
    Blaxill, Jonathan M.
    Blackman, Daniel J.
    Malkin, Christopher J.
    Wheatcroft, Stephen B.
    Greenwood, John P.
    HEART, 2017, 103 : A22 - A22
  • [4] Outcomes after percutaneous coronary intervention (PCI) in contemporary Australian practice: insights from a large multi-centre registry
    Alfiadh, A.
    Clark, D.
    Duffy, S.
    Farouque, O.
    New, G.
    Horrigan, M.
    Black, A.
    Ajani, A.
    Lew, R.
    Brennan, A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 462 - 462
  • [5] COMPARED THE CLINICAL OUTCOMES OF CLOPIDOGREL AND TICAGRELOR IN STABILIZED PATIENTS WITH ACUTE CORONARY SYNDROME AFTER PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A REAL-WORLD REGISTRY
    Zhang, Yunnan
    Han, Jialun
    Shi, Xiujin
    Peng, Wenxing
    Lin, Yang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1030 - 1030
  • [6] Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention
    Koshy, Anoop N.
    Giustino, Gennaro
    Sartori, Samantha
    Kyaw, Htoo
    Yadav, Mayank
    Zhang, Zhongjie
    Hooda, Amit
    Farooq, Ali
    Krishnamoorthy, Parasuram
    Sweeny, Joseph M.
    Khera, Sahil
    Serrao, Gregory W.
    Sharma, Raman
    Suleman, Javed
    Dangas, George
    Kini, Annapoorna S.
    Mehran, Roxana
    Sharma, Samin K.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (22) : 2270 - 2280
  • [7] Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention
    Sucato, Vincenzo
    Corrado, Egle
    Castellana, Carmelo
    Carella, Michele
    Raso, Simona
    Coppola, Giuseppe
    Andolina, Giuseppe
    Novo, Giuseppina
    Evola, Salvatore
    Novo, Salvatore
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2017, 18 (06) : 450 - 451
  • [8] Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry
    Zhang, Yunnan
    Peng, Wenxing
    Shi, Xiujin
    Han, Jialun
    Wang, Yifan
    Fang, Zhenwei
    Lin, Yang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [9] COSTS OF CARDIOVASCULAR READMISSIONS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: DATA FROM A LARGE MULTI-CENTRE AUSTRALIAN REGISTRY
    Ariyaratne, T., V
    Ademi, Z.
    Duffy, S. J.
    Andrianopoulos, N.
    Billah, B.
    Brennan, A. L.
    Clark, D. J.
    New, G.
    Black, A.
    Ajani, A. E.
    Yan, B. P.
    Reid, C. M.
    VALUE IN HEALTH, 2012, 15 (07) : A403 - A404
  • [10] Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention (vol 6, e000951, 2019)
    Krishnamurthy, A.
    Keeble, C.
    Anderson, M.
    OPEN HEART, 2019, 6 (02):
12345